1 / 42

I mm un e -m ed i a t e d d i sease and the M ic r o /Ma c r o b i o m e

I mm un e -m ed i a t e d d i sease and the M ic r o /Ma c r o b i o m e. D a v i d E . Elli o t t , M D , P hD. O u t li n e - Lea r n i ng O bject i v es. I m m u n e - m e d i a t ed d i s ea s e a n d t h e E n v i r o n m e n t B r i e f i n t o t o I m m u n e R eg u l a t i on

gvelasco
Télécharger la présentation

I mm un e -m ed i a t e d d i sease and the M ic r o /Ma c r o b i o m e

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Immune-mediateddisease andthe Micro/Macrobiome DavidE.Elliott,MD, PhD

  2. Outline-LearningObjectives • Immune-mediateddiseaseandtheEnvironment • BriefintotoImmuneRegulation • Micro/Macro-biomeasacontextsetter • Microbiomeanddisease • C.difficilecolitisroleofFMT • IBD • Celiac • MS • Helicobacterpylori • Pleaseinterruptandaskquestionsduringtalk • Conversationinstructsbetterthanlecture

  3. Immune-MediatedDisease • Thereareover80well-recognizedimmune-mediateddiseases. Examplesinclude;T1D,RA,MS,Celiac,IBD,Psoriasis,Lupus,Asthma,Grave’s,ITP, … • Most areincreasingin frequencyandarerareinareaswithless industrialization. (fromBach,N.E.J.M.347:911)

  4. InflammatoryBowelDisease NormalColon Crohn’sColitis

  5. Normal Crohn’sDisease DysregulatedInflammation RegulatedInflammation

  6. >160Genes/LociareImplicatedinIBDbyGWAS Both fromLeesGut60:17392011andVanLimbergenNat.Rev.Gastro/Hep11:3722014

  7. EtiologyofIBD Nurture Nature IBD Genes Environment

  8. “Ecologic”EventsinImmunity • GeneticpredispositionexplainsaminorcomponentoftheriskforIBD • ~50%concordanceforCrohn’sdiseasein monozygotictwins • <20%concordanceforUC inmonozygotictwin pairs • (Halfvarson,Gastroenterology124:1767) • Theimmuneresponseissensitivetocontext. ̶ ̶ ̶ ̶ Strength ofreceptorengagement(stochastic selection)Selectionofco-signalingmolecules(perceptionofdanger)Proteoglycanmatrix signals( perceptionoftissuedamage)Pre-existingcytokinemilieu(dictatesresponseprofiles) • TheMicrobiomehelpstosetimmunologiccontext

  9. IL17 ALLERGY AUTOIMMUNITY IL21 TNF IL22 RoRt TNF IL5 IL4 IL13 IL10 IFN IL2 IL6 Th17 Th22 IL6,TGF, IL23,IL1 Th1 Th2 IL12 IL4 APC Th0 TGF IL9 Th9Tr1 TGF nTreg IL10 IL27 Th3 FoxP3 IL2 CD25+ FoxP3 Gata3 IL10 TOLERANCE ANERGY TGF

  10. #Biomics • Current focusisonbacteria • >10,000publicationson gutmicrobiomeinlast5years • ~1000to 1200 bacterialspeciesinhabithuman gut • Each personhas~160 bacterialspeciesin gut(functionalcore) • Healthyidenticaltwinswillhavesimilarbutdifferentbacteriapopulation • Populationisrelatively stablebutcanshift–“PreBiotics” • Dysbiosis=pathologicallyskewed populationofgut bacteria • CausevsEffectofillness • (Lloyd-Price,et.al. ThehealthyhumanmicrobiomeGenomeMed8:512016) • Moreneglectedare theecologicalcontributionof: • Archaea (e.g. Methanobrevibactersmithii) • Virus(+/-RNA,ss/dsDNA,bacteriophages) • Fungi(yeast- Candida,Malassezia,andSaccharomyces) • Protozoa (Blastocystis,Entamoeba,etc...) • Helminths(worldwide50-90%of peoplecarryhelminths) • Oldfriendshypothesis–disappearingbiome

  11. Alteringthe‘BiometoTreatImmune- MediatedInflammatoryDisease(IMID) • Assumptions: • Immunemediateddiseasesare duetoimmunedysregulation • Immunedysregulationis contextual • Themicrobiomehelpssetcontext • Changingthe‘biome maytreatdisease • Examples • C.difficilecolitis(not anIMIDbutbestexampleforbiomeRx) • IBD • Celiac • MS • Helicobacterpylori gastritis

  12. C.difficlecolitis • Plasmid-directedproductionoftoxinsthatmediatedestructionofcolonicepithelium • Causedbyovergrowth ofClostridiumdifficileoftenafterantibiotictreatment • Treatedwithspecificantibioticsbut Clostridiaaresporeformersandrecurrentinfectionsarecommon • Recurrent/refractoryC.difficlecanbetreatedwithFecalMicrobiotaTransplant(FMT) Pseudomembranouscolitis Summitlesion

  13. FMT–refractoryC.diff • AKA-Stooltransplant • FMTis anestablishedtreatmentforRCDI • ~92%effective (betterthanrepeatedvancomycin) • Lowerdelivery ~95%betterthanupperdelivery(~88%) • Nodifferencebetweenfreshorfrozen • Repeatedattemptsaddincrementalefficacy • Donorsneedextensivescreening • (Quraishi,et.al.Systematicreviewwithmeta-analysis:…AlimentPharmacolTher.46:4792017) • OpenBiome(commercialsourceoffrozenpoo) • Youtoocanbecomea stooldonor(Bostononly)!!!! • SynPoop-groups aretrying tocreatestandardizedculturedFM

  14. IBD • IBDdoesnot developingerm-freeanimals • NewonsetpediatricCrohn’sdisease(668patients) • Increasedabundance(Enterobacteriaceae,Pasteurellacaea,Veillonellaceae, andFusobacteriaceae) • Decreasedabundance(Erysipelotrichales,Bacteroidales,andClostridiale) • Dysbiosisisexacerbatedbyantibiotictreatment • (Gevers,et. al.Thetreatment-naïvemicrobiomein new-onsetCrohn’sdisease.CellHostMicrobe.15:382,2014) • Othersfindsimilarchanges(dysbiosis) • CausevsEffectunknown • FMTinIBDisbeingstudied • Repeated(weeklyx6)FMT appearstobeeffectiveinUC (remission:24%FMT 5%Placebo,p=0.03) • Stooldiversityimprovedinrecipients • (Moayyedi,et. al.FecalMicrobiotaTransplantationInducesRemission in PatientsWith ActiveUlcerativeColitis…Gastroenterology149:102,2015) • –NoevidenceyetforefficacyinCrohn’s

  15. RiseinIBD–EasternEurope

  16. EradicationofHookworm • JohnD.Rockefeller initiated • ~1909–SanitaryCommission • Globaleffortassistedby advancesinhygiene • DecreaseinhookworminUSAovertime • Hookwormisno longerendemicinUSA. • Hookwormcouldhelpexplainthepriornorth- south gradient.

  17. HelminthsandtheHumanGenome • Allvertebrateanimalscarryhelminths • Carriageof helminthsappearstohaveinfluencedour genevariation • ITGAV,COL4A1,ITGA8,FLNB,ITGA9,ITGB8,ITGAM,ITGBL1,COL4A2, COL1A2,DOCK2,PTK2B,ITGAX,FYN,MAPK13,LAMA2,ITGAL,LIMS1, COL24A1,ELMO1,COL15A1,DOCK1,MAPK14,COL9A3,VAMP3,SOCS6,PLCH2,PLCB1,GRB2,GNG10,ITPR1,CXCR6,MYH14,ITGA9,MYO3B, PLA2G4B,GNAQ,CAMK2A,PLCL1,CAMK2D,ITGAM,CCR9,COL1A2, ITGB7,PAK7,VAV2,PLCD3,ADCY2,PTK2B,PLCE1,RELA,ITPR2,CCL20, PLA2G4A,COL23A1,IL4,KCNS3,CTLA4,DPP10,TLR4,PTGER2,GATA3, PHF11,IL10,NPSR1,ADRB2,IKZF2,ADRA1A, • Variationincludespathwaysconferringriskforinflammatory and autoimmunedisease (Fumagalli,BMC EvolutionaryBiology10:264,2010)

  18. HelminthsandIBDEpidemiology • Priorhookworminfectionappearstoprotectfrom Crohn’sdisease (Kabeerdoss,Aliment.Pharmacol.Ther.;34:923,2011) • Casecontrol study in Vellore,India:75 Control/ 78 Crohn’s • Assayedin vitro PBMC reactivity tohookwormantigens • IFNELISPOT(+):48%control26%Crohn’sdisease(p<0.005) • • %CD3+CD69+shift:3.16+0.74control,0.90+0.48Crohn’s(p<0.001) • PriorhelminthexposureappearstoprotectfromIBD • (Chu,Inflamm.BowelDis.19:614,2013) • Casecontrol study in CapeTown,SouthAfrica • 88Crohn’sdisease,63ulcerativecolitis,219controls • 56%Crohn’s,66%UC patientsand91%controlsreportedchildhood helminthexposure(p<0.001) • • AdjustedOddsRatioCD=0.2[0.1-0.4], UC=0.2[0.1-0.6]

  19. Heligmosomoides(polygyrus)bakeri • Intestinalnematodeofmice. • completelyentericlifecycle • AcquiredbyingestingsmallL3larvae. • larvaeare about0.3mmlong • Larvaeandadultwormsresideintheduodenum.

  20. BasicH.bakeriprotocol 2 wks Sham Treatment Analyze C57BL/6 2 wks Analyze Hpb L3byGastricLavage

  21. H.bakeriexposurealtersLPMC cytokineexpression ELISAof48hrculturesfromCD3-stimulatedcells.

  22. H.bakeriin CD25-depletiontransfer colitisprotocol Remove CD25+ andB220+cells B6WT Spleen B6reconstitutedRag1-/- B6Rag1-/- Sham 2 wksRx Analyze Piroxicam for2wks 2 wks Analyze HpbL3 Colitic

  23. H.bakeriexposurereverses establishedtransfercolitis 3.78±0.06 p<0.01 1.54±0.13

  24. UlcerativeColitisTrialResults PhaseI PhaseI Response ( UCDAI>4) ChangeinUCDAIComponentScores

  25. CeliacDisease • What is it? • Inappropriateimmuneresponsetogluten WillemKarelDicke • Glutenisatermforstorageproteinsincereal grains • Wheat,Rye,Barley • ?Oats • Delayed-type(TypeIV)hypersensitivityresponse • WheatallergyinitiallydescribedbyWillemDicke • Resultsin chronicintestinalinflammation • Allergyvs. ImmuneMediatedInflammationvs.AutoimmuneDisease

  26. EndoscopicCharacter Celiac Normal

  27. Normal Celiac IEL

  28. Celiacdisease-Genetics MHCClassII&moleculesformdimersthat presentantigenstoTcells. • Morethan95%ofpatientshaveeitherHLA-DQ2(1*5011*0201)ClassIIHLA-DQ8(1*3011*0302)ClassII   • About30%ofthepopulationalsoexpressthesedimers. • DQ2orDQ8arerequiredandcontributebutdonotcauseceliacdisease.

  29. HLA-DQ2bindsglutenpeptides PQPQLPY tTG NH2 PQPELPY P=Proline Q=Glutamine L=Leucine Y=TyrosineE=Glutamate (Kim,PNAS 101:4175,2004)

  30. 5EpitopesinaPoorlyDigestible 33aaGliadinPeptide PQPQLPYPQ PYPQPQLPY ..LQLPFPQPQLPYPQPQLPYPQPQLPYPQPQPF.. P=Proline Q=Glutamine L=Leucine Y=Tyrosine F=Phenylalanine (Shan,Science297:2275,2002)

  31. Celiacandthe‘biome • Casecontrol studyon2,933celiacpatientsmatchedwith28,262controlsfound a positivecorrelation betweenantibiotic use,and subsequentceliac(oddsratio(OR)= 1.40;CI=1.27–1.53). • (Marild,et. al. Antibioticexposureanddevelopment ofcoeliacdiseaseBMC Gastro.13:109,2013) • Duodenalbacteriafromceliacpatientsgiventogerm-freemice alterdigestionofglutentoincreaseimmunopathogenicpeptideavailability. • Pseudomonasaeruginosaseeninceliacincreasedantigenicity • Lactobacillusstrainsfromnon-celiaccontrols reducedantigenicity(Camineroet.al. (2016)Duodenalbacteriafrompatients withceliacdisease…affectgluten breakdownandimmunogenicity.Gastro.151:670,2016) • Celiacpatientshave more G-andfewG+ bacteriaandpopulationschangewithgluten-freediet

  32. Celiacandhelminths • Investigatorsare studyingtheeffectof helminthexposureon celiacdisease. • Utilizedhookworm(Necatoramericanus) • Patientsweregiven20larvae(transdermal)andthenmicro-challenged withlow-dosegluten • Glutenexposuredidnotcauseexpectedduodenalatrophyorincrease anti-tTG,qualityoflifescoresincreased,intestinalTcellIFNγdeclined andFoxp3+Tregsincreased. • “Microbialdiversity”wasenrichedinpatientsharboringN.americanus • (Croeseet. al. ExperimentalhookworminfectionandglutenmicrochallengepromotetoleranceJ AllergyClinImmunol135:508,2015;Giacommet. al.Experimentalhookworminfection…increasedmicrobialrichnessinceliacsubjects.Sci. Reports5:13797,2015)

  33. MultipleSclerosis(MS) • MSis causedbyimmune-mediateddestructionofinsulatingmyelininthecentralnervoussystemcausingaxon damage • Twomajorforms • Relapsing/remittingsecondaryprogressive • Primaryprogressive • Animalmodel– ExperimentalAutoimmuneEncephalitis(EAE) • Microbiome • Nomajorfindingsbutinacasecontrol study;MScasesexhibitedhigherabundancesofMethanobrevibacter(Archaea)andAkkermansiaandlowerButyricimonas • (Jangi,etal.Alterationsof thehuman gutmicrobiomeinMS. Nat.Commun. 7:12015,2016)

  34. MSandhelminths • Casecontrolstudiessuggestthat: • Helminthcarriagereducesdiseaseseverity • (Correale,Associationbetweenparasiteinfectionandimmuneresponses inmultiplesclerosis.Ann Neurol. 61:97.2007) • Eradicationofhelminthsexacerbatesdisease • (Correale,Theimpactofparasiteinfectionson thecourseof multiplesclerosis.J.Neuroimmunol. 233:6,2011) • Therapeutichelminthexposurecanalterimmunecircuits andmayinfluencediseasecourse(open-labelstudy). • (Fleming,etal. Probiotichelminthadministrationinrelapsing-remittingmultiplesclerosis: a phase1study. MultScler.17:743,2011)

  35. HelicobacterpyloriGastritis/Duodenitis • MotileGram(-)spiral-shapedrodbacteria • Mostcommoninfectionworldwide(>50%) • Infectionassociatedwithdecreasedsocioeconomicstatus • Prevalencevariesbyageandgroup(nextslide) • Mostinfectionsareasymptomatic

  36. Helicobacterpylori

  37. H.pylori andPUD • 2005 • DiscoveredasagentofPUD • Marshall&Warren.Lancet8390:13111984 • H.pyloricausesbothacuteandchronicgastritis • Most(~90%)ofpatientswithPUDandnotusingNSAIDshaveH.pylori. • Lifetimeriskvaries3%(US)to25%(Japan) • Hp+ NSAIDsincreasesPUDrisk60fold • EradicationofH.pylorireducesulcerrecurrence • – from~90%to10%.

  38. H.pylori andpepticulcer disease • H.pyloridoesnotinvade(remainslumenal) • H.pylorisecretesenzymesandtoxins • AllmakeUrease • Splitsureainto bicarbonate+ NH3 • Buffersacid • MoststrainsmakeVacAandCagA • VacAcausesvacuolationofepithelialcells • CagAincreasescytokineproductionbyepithelialcells • Uncertaincontributiontopathogenicity • Immuneresponseiswhatcauses disease • –ChronicinflammationdrivesPUDandotherpathology

  39. H.pylori –OtherIllness • AtrophicGastritis • CommoncauseofB12deficiencyintheelderly • GastricCancer(Adenocarcinoma) • H.pyloriisclassifiedasType1(definite)carcinogen • Themajorcauseofgastriccancerworldwide • MALTLymphoma(98%haveH.pylori) • MALT = Mucosa-associatedLymphoidTissue • B-celltumorinfiltratingthegastricmucosa • About80%regresswithH.pylorieradication

  40. H.pylori diagnosis/treatment • Diagnosis • Serology(IgGAnti-Hpantibody) • Best screeningtestif on PPI • Remains+ for~2yrs afterRx • Ureasebreathtest • StoolAgtest • Gastricbiopsy(evaluationofPUD) Giemsa,KacarInternetJournalofPathology.3:2004 • Histology • urease“CLO”testing • Treatment • Iffound–> treat. • Eradicationrateisabout75% • Triple therapy(PPI+2antibioticsfor2weeks) • ClarithromycinplusAmpicillinorMetronidazole

  41. HelicobacterpyloriMicrobiome • Eradication hasnoeffectongeneraldiversitybut • reducesrelativeabundanceofBacterioidetes • withcorrespondingincreaseinFirmicutes • (Wan-ChenYap,etal.Helicobacter pyloriEradicationCausesPerturbationof the HumanGutMicrobiomeinYoungAdults. PlosOne11:e0151893,2016) • Otherbacteriainhabitthestomach • H.pyloripathologymaybe influencedbyotherbugs • (ShehTheroleof thegastrointestinalmicrobiomein Helicobacterpyloripathogenesis.GutMicrobes.4:505,2013) • HelminthinfectionaltersH.pylori pathologyandmay decreasecancerrisk • (Ek, et al. Serologicevidencethatascarisandtoxoplasmainfectionsimpactinflammatoryresponses toHelicobacterpyloriinColombians.Helicobacter.17:107-15,2012)

  42. Immune-mediateddisease andthe Micro/Macrobiome Questions?

More Related